Correlation Between Iovance Biotherapeutics and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Neurocrine Biosciences, you can compare the effects of market volatilities on Iovance Biotherapeutics and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Neurocrine Biosciences.
Diversification Opportunities for Iovance Biotherapeutics and Neurocrine Biosciences
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Iovance and Neurocrine is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Neurocrine Biosciences
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 2.03 times less return on investment than Neurocrine Biosciences. In addition to that, Iovance Biotherapeutics is 2.69 times more volatile than Neurocrine Biosciences. It trades about 0.01 of its total potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.03 per unit of volatility. If you would invest 9,411 in Neurocrine Biosciences on December 4, 2024 and sell it today you would earn a total of 1,900 from holding Neurocrine Biosciences or generate 20.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. Neurocrine Biosciences
Performance |
| Timeline |
| Iovance Biotherapeutics |
| Neurocrine Biosciences |
Iovance Biotherapeutics and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and Neurocrine Biosciences
The main advantage of trading using opposite Iovance Biotherapeutics and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |